11/19/2024
3:20 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
3:21 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
9:30 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
7:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
5:33 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
5:23 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
5:24 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/29/2024
5:26 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
5:27 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/14/2024
11:15 PM | Seres Therapeutics (Filer)
| Form EFFECT | |
10/11/2024
3:34 PM | Seres Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
7:15 AM | NESTLE SA (Reporting)
Seres Therapeutics (Issuer)
Societe des Produits Nestle S.A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
7:15 AM | NESTLE SA (Filed by)
Seres Therapeutics (Subject)
| Form SC 13D/A | |
10/01/2024
3:46 PM | Seres Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/26/2024
3:13 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
7:30 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
09/12/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
3:36 PM | Seres Therapeutics (Filer)
| Form DEFM14A | |
08/19/2024
4:38 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:42 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:45 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:48 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:29 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2024
4:36 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
5:52 AM | Seres Therapeutics (Filer)
| Form PREM14A | |
08/15/2024
5:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
4:21 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/13/2024
9:38 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:08 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/07/2024
7:38 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
7:39 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
4:27 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
4:28 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
4:28 PM | Seres Therapeutics (Filer)
| Form DEFA14A | |
08/06/2024
3:15 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
6:39 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:41 AM | Seres Therapeutics (Filer)
| Form DEFA14A | |
05/17/2024
7:16 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:17 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:18 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
05/17/2024
7:18 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:23 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
7:14 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
9:00 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
4:18 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
3:45 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Ausiello Dennis A (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Dere Willard H (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Fraser Claire (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Kender Richard N (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:45 PM | Graves Kurt (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/08/2024
3:30 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
03/27/2024
3:20 PM | Seres Therapeutics (Issuer)
Thorell Marella (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
9:01 AM | Seres Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
9:13 AM | Seres Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/05/2024
9:18 AM | Seres Therapeutics (Filer)
| Form DEF 14A | |
03/05/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:06 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
8:48 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:42 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:21 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:29 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:31 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:13 PM | Arkowitz David (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
8:15 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:23 AM | JANUS HENDERSON GROUP PLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:49 AM | FMR LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024
3:01 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G | |
01/10/2024
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
